Cargando…

Dipalmitoylphosphatidic acid inhibits tumor growth in triple-negative breast cancer

Triple-negative breast cancer (TNBC) is a subtype of breast cancer with a poor prognosis, accounting for approximately 12-24% of breast cancer cases. Accumulating evidence has indicated that there is no effective targeted therapy available for TNBC. Dipalmitoylphosphatidic acid (DPPA) is a bioactive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Qian-Qian, Chen, Jian, Zhou, Da-Lei, Duan, You-Fa, Qi, Cui-Ling, Li, Jiang-Chao, He, Xiao-Dong, Zhang, Min, Yang, Yong-Xia, Wang, Lijing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436567/ https://www.ncbi.nlm.nih.gov/pubmed/28529455 http://dx.doi.org/10.7150/ijbs.16290

Ejemplares similares

Dipalmitoylphosphatidic acid inhibits breast cancer growth by suppressing angiogenesis via inhibition of the CUX1/FGF1/HGF signalling pathway
por: Chen, Jian, et al.
Publicado: (2018)

Knockdown of SPON2 inhibits the growth of triple-negative breast cancer
por: Hu, Xueyi, et al.
Publicado: (2023)

IKKα inhibition re-sensitizes acquired adriamycin-resistant triple negative breast cancer cells to chemotherapy-induced apoptosis
por: Liao, Jian, et al.
Publicado: (2023)

Unraveling the Pivotal Network of Ultrasound and Somatic Mutations in Triple-Negative and Non-Triple-Negative Breast Cancer
por: Huang, Yunxia, et al.
Publicado: (2023)

Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer
por: You, Kyu Sic, et al.
Publicado: (2021)

Hinokitiol-iron complex is a ferroptosis inducer to inhibit triple-negative breast tumor growth
por: Zhao, Hongting, et al.
Publicado: (2023)

MiR-940 Inhibited Cell Growth and Migration in Triple-Negative Breast Cancer
por: Hou, Lingmi, et al.
Publicado: (2016)

Male triple negative axillary accessory breast cancer—a case report
por: Li, Chao, et al.
Publicado: (2022)

GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer
por: Wu, Qin, et al.
Publicado: (2020)

Immune-related biomarkers in triple-negative breast cancer
por: Zhang, Juan, et al.
Publicado: (2021)

PRMT5 reduces immunotherapy efficacy in triple-negative breast cancer by methylating KEAP1 and inhibiting ferroptosis
por: Wang, Zhe, et al.
Publicado: (2023)

Knockdown of SERPINE1 reverses resistance of triple-negative breast cancer to paclitaxel via suppression of VEGFA
por: Zhang, Qian, et al.
Publicado: (2020)

Combined inhibition of EGFR and c-ABL suppresses the growth of triple-negative breast cancer growth through inhibition of HOTAIR
por: Wang, Yuan-Liang, et al.
Publicado: (2015)

Apigenin suppresses the stem cell-like properties of triple-negative breast cancer cells by inhibiting YAP/TAZ activity
por: Li, Ying-Wei, et al.
Publicado: (2018)

MiR-133 Targets YES1 and Inhibits the Growth of Triple-Negative Breast Cancer Cells
por: Zhang, Guochen, et al.
Publicado: (2020)

Progesterone suppresses triple-negative breast cancer growth and metastasis to the brain via membrane progesterone receptor α
por: Zhou, Li, et al.
Publicado: (2017)

HRD1 inhibits fatty acid oxidation and tumorigenesis by ubiquitinating CPT2 in triple‐negative breast cancer
por: Guo, Xin, et al.
Publicado: (2020)

Syntelin inhibits triple-negative breast cancer cell proliferation and metastasis
por: Mullen, McKay, et al.
Publicado: (2021)

An EMT-Related Gene Signature to Predict the Prognosis of Triple-Negative Breast Cancer
por: Zhang, Bo, et al.
Publicado: (2023)

Inhibition of APE1 Expression Enhances the Antitumor Activity of Olaparib in Triple-Negative Breast Cancer
por: Jian, Dan, et al.
Publicado: (2022)

NUMB negatively regulates the epithelial-mesenchymal transition of triple-negative breast cancer by antagonizing Notch signaling
por: Zhang, Jianchao, et al.
Publicado: (2016)

ED SUM: Triple-negative breast cancer is inhibited by depleting mitochondrial copper in mice.: Mitochondrial copper depletion suppresses triple-negative breast cancer in mice
por: Cui, Liyang, et al.
Publicado: (2020)

Thioridazine combined with carboplatin results in synergistic inhibition of triple negative breast cancer by targeting cancer stem cells
por: Wang, Yi, et al.
Publicado: (2022)

Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer
por: Jiang, Lin, et al.
Publicado: (2022)

A Combined Nomogram Model to Predict Disease-free Survival in Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
por: Xia, Bingqing, et al.
Publicado: (2021)

ELOVL2-AS1 inhibits migration of triple negative breast cancer
por: Zhu, Mingda, et al.
Publicado: (2022)

Inhibition of Triple-Negative Breast Cancer Tumor Growth by Electroacupuncture with Encircled Needling and Its Mechanisms in a Mice Xenograft Model
por: Jiang, Xin, et al.
Publicado: (2019)

ONC201 activates ER stress to inhibit the growth of triple-negative breast cancer cells
por: Yuan, Xun, et al.
Publicado: (2017)

OSW‐1 inhibits tumor growth and metastasis by NFATc2 on triple‐negative breast cancer
por: Ding, Xiaorong, et al.
Publicado: (2020)

Involvement of actin cytoskeletal modifications in the inhibition of triple-negative breast cancer growth and metastasis by nimbolide
por: Arumugam, Arunkumar, et al.
Publicado: (2021)

Growth Inhibition of Triple-Negative Breast Cancer: The Role of Spatiotemporal Delivery of Neoadjuvant Doxorubicin and Cisplatin
por: Salerno, Dominick, et al.
Publicado: (2021)

Edelfosine nanoemulsions inhibit tumor growth of triple negative breast cancer in zebrafish xenograft model
por: Saraiva, Sofia M., et al.
Publicado: (2021)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

Sequential targeting of PARP with carboplatin inhibits primary tumour growth and distant metastasis in triple-negative breast cancer
por: Beniey, Michèle, et al.
Publicado: (2023)

Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma
por: Zhang, Qian-Qian, et al.
Publicado: (2014)

The phosphatase PPM1A inhibits triple negative breast cancer growth by blocking cell cycle progression
por: Mazumdar, Abhijit, et al.
Publicado: (2019)

Current landscape of personalized clinical treatments for triple-negative breast cancer
por: Zhang, Jun, et al.
Publicado: (2022)

Rutaecarpine induces the differentiation of triple-negative breast cancer cells through inhibiting fumarate hydratase
por: Lei, Jie, et al.
Publicado: (2023)

Disabling the Nuclear Translocalization of RelA/NF-κB by a Small Molecule Inhibits Triple-Negative Breast Cancer Growth
por: Kanzaki, Hirotaka, et al.
Publicado: (2021)

Preparation, Characterization, and Inhibition of Hyaluronic Acid Oligosaccharides in Triple-Negative Breast Cancer
por: Han, Wenwei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c0h223j5pteg53droaqsksupe3